文献速递炎症性肠病消化道肿瘤与早癌消化内镜

炎症性肠病患者异型增生后进展为更晚期病变的风险

Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-06-13

该多中心回顾性分析纳入比利时7家中心的410例IBD患者,评估低级别或高级别异型增生诊断后进展为更晚期病变的风险。LGD患者7%进展为HGD或CAC,HGD患者14%进展为CAC;初始HGD后10年CAC累积发生率为24.3%,LGD后为8.5%(P < .05)。

要点

  • LGD患者7%在中位86个月后进展为HGD或CAC。
  • HGD患者14%在中位180个月后进展为CAC。
  • 异时性病变、非息肉样病变和结肠狭窄与LGD后更晚期病变风险相关。

核心结论

  • 在比利时7家医学中心的病理数据分析中,LGD或HGD检测后进展为更晚期病变的检出率较低,考虑到大多数病变已被切除。
  • LGD后进展为更晚期病变的主要风险因素为异时性病变、非息肉样病变和结肠狭窄。

研究设计与样本

  • 多中心回顾性分析,数据来自比利时7家三级转诊区域或学术中心。
  • 共纳入410例IBD患者,识别813处病变(616处LGD、64处HGD、133处CAC);299例(73%)有异型增生,111例(27%)有CAC。

主要发现

  • 287例LGD患者中21例(7%)在中位86个月(IQR 34-214)后进展为更晚期病变(HGD或CAC)。
  • 28例HGD患者中4例(14%)在中位180个月(IQR 23-444)后进展为CAC。
  • 初始HGD诊断后10年CAC总体累积发生率为24.3%,初始LGD诊断后为8.5%(P < .05)。
  • 异时性病变、非息肉样病变和结肠狭窄与LGD后更晚期病变发生风险相关(P < .05)。
  • 内镜下识别的630处异型增生病变中,545处(86%)在同一操作、随访内镜或手术中被切除。

关键数值与推荐

  • 111例CAC患者中95例(86%)既往未检测到异型增生。
  • 这95例中的64例(67%)CAC发生在欧洲克罗恩病和结肠炎组织推荐的筛查或监测期之外。

临床怎么用

  • LGD或HGD诊断后进展为更晚期病变的检出率较低,需考虑大多数病变已被切除。
  • LGD后进展为更晚期病变的主要风险因素为异时性病变、非息肉样病变和结肠狭窄。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patients with inflammatory bowel diseases (IBD) have increased risks of dysplasia and colitis-associated cancer (CAC). We evaluated the risk of development of high-grade dysplasia (HGD) or CAC after diagnosis of dysplasia using data from a national cohort of patients with IBD. METHODS: We performed a multicenter retrospective analysis of data collected from 7 tertiary referral regional or academic centers in Belgium. In searches of IBD pathology databases, we identified 813 lesions (616 low-grade dysplasias [LGDs], 64 high-grade dysplasias [HGDs], and 133 CACs) in 410 patients with IBD: 299 had dysplasia (73%) and 111 had CAC (27%). The primary aim was to determine the risk of more-advanced lesions after diagnosis of LGD or HGD. RESULTS: Of the 287 patients with LGD, 21 (7%) developed more-advanced lesions (HGD or CAC) after a median time period of 86 months (interquartile range, 34-214). Of the 28 patients with HGD, 4 (14%) developed CAC after a median time period of 180 months (interquartile range, 23-444). The overall cumulative incidence of CAC at 10 years after an initial diagnosis of HGD was 24.3% and after an initial diagnosis of LGD was 8.5% (P < .05). Metachronous lesions, non-polypoid lesions, and colonic stricture were associated with risk of occurrence of more-advanced lesions after LGD (P < .05). Of the 630 dysplastic lesions identified during endoscopy, 545 (86%) were removed during the same procedure or during a follow-up endoscopy or by surgery. Of 111 patients with CAC, 95 (86%) did not have prior detection of dysplasia and 64 of these 95 patients (67%) developed CAC outside of the screening or surveillance period recommended by the European Crohn's and Colitis Organisation. CONCLUSIONS: In an analysis of pathology data from 7 medical centers in Belgium, we found a low rate of detection of more-advanced lesions following detection of LGD or HGD-taking into account that most of the lesions were removed. Main risk factors for development of more-advanced lesions after LGD were metachronous lesions, non-polypoid lesions, and colon strictures.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Cremer A, Demetter P, De Vos M, et al. Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia. Clin Gastroenterol Hepatol. 2019. PMID: 31202983. doi:10.1016/j.cgh.2019.05.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。